Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2017 2
2018 3
2019 2
2020 3
2021 8
2022 5
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis.
Arida A, Legaki AI, Kravvariti E, Protogerou A, Sfikakis PP, Chatzigeorgiou A. Arida A, et al. Among authors: kravvariti e. Front Cardiovasc Med. 2021 Oct 8;8:738764. doi: 10.3389/fcvm.2021.738764. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34692791 Free PMC article.
The Relevance and Added Value of Geriatric Medicine (GM): Introducing GM to Non-Geriatricians.
Kotsani M, Kravvariti E, Avgerinou C, Panagiotakis S, Bograkou Tzanetakou K, Antoniadou E, Karamanof G, Karampeazis A, Koutsouri A, Panagiotopoulou K, Soulis G, Stolakis K, Georgiopoulos I, Benetos A. Kotsani M, et al. Among authors: kravvariti e. J Clin Med. 2021 Jul 7;10(14):3018. doi: 10.3390/jcm10143018. J Clin Med. 2021. PMID: 34300184 Free PMC article. Review.
Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials.
Yavropoulou MP, Kasdagli MI, Makras P, Diomatari KM, Anastasilakis AD, Mitsikostas DD, Kassi E, Sfikakis PP, Kravvariti E. Yavropoulou MP, et al. Among authors: kravvariti e. Maturitas. 2024 Jan;179:107874. doi: 10.1016/j.maturitas.2023.107874. Epub 2023 Oct 31. Maturitas. 2024. PMID: 37976923 Review.
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.
Papagoras C, Zioga N, Papadopoulos V, Gerolymatou N, Kalavri E, Bounos C, Simopoulou T, Fragoulis GE, Panopoulos S, Fragiadaki K, Evangelatos G, Bournia VK, Arida A, Karamanakos A, Pappa M, Kravvariti E, Deftereou K, Kougkas N, Zampeli E, Kataxaki E, Melissaropoulos K, Barouta G, Panagiotopoulos A, Koutsianas C, Liossis SN, Georgiou P, Dimitroulas T, Tektonidou MG, Bogdanos DP, Elezoglou A, Voulgari PV, Sfikakis PP, Vassilopoulos D. Papagoras C, et al. Among authors: kravvariti e. Clin Rheumatol. 2023 Dec;42(12):3375-3385. doi: 10.1007/s10067-023-06769-4. Epub 2023 Sep 21. Clin Rheumatol. 2023. PMID: 37731083 Free PMC article.
Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: The ATTICA cohort study (2002-2022).
Kouvari M, Chrysohoou C, Damigou E, Barkas F, Kravvariti E, Liberopoulos E, Tsioufis C, Sfikakis PP, Pitsavos C, Panagiotakos D, Mantzoros CS; ATTICA Study group. Kouvari M, et al. Among authors: kravvariti e. Clin Nutr. 2024 Mar;43(3):900-908. doi: 10.1016/j.clnu.2024.02.006. Epub 2024 Feb 10. Clin Nutr. 2024. PMID: 38387279
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases.
Fragoulis GE, Karamanakos A, Arida A, Bournia VK, Evangelatos G, Fanouriakis A, Fragiadaki K, Kravvariti E, Laskari K, Panopoulos S, Papazoglou N, Pappa M, Tektonidou MG, Sfikakis PP. Fragoulis GE, et al. Among authors: kravvariti e. RMD Open. 2022 Mar;8(1):e002279. doi: 10.1136/rmdopen-2022-002279. RMD Open. 2022. PMID: 35246472 Free PMC article. No abstract available.
36 results